Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2017 Jan 1.

Published in final edited form as: Bone Marrow Transplant. 2015 Sep 14;51(1):67–71. doi: 10.1038/bmt.2015.211

Table 3.

Infusional toxicities after amifostine; N (%; 95% CI)

Grades 1–2^*	Melphalan	Melphalan
Grades 1–2^*	280 (n=66)	200 (n=65)
Hypotension	9 (14%; 5–22%)	10 (15%; 7–24%)
Nausea	18 (27%; 17–38%)	15 (23%; 13–33%)
Flushing	11 (17%; 8–26%)	11 (17%; 8–26%)
Sneezing	3 (5%; 0–10%)	5 (8%; 1–14%)
Drowsiness	2 (3%; 0–7%)	3 (5%; 0–10%)